Carotid artery stenting (CAS), an endovascular treatment for severe carotid artery occlusive disease, is increasingly considered a complimentary procedure to carotid endarterectomy. One reason for the acceptance of CAS as a viable treatment alternative is cerebral protection devices (CPDs), which can reduce the embolic load in the cerebral vasculature. One particular type of CPD, distal protection filters (DPFs), are a popular choice due to their ability to allow distal perfusion peri-procedurally while filtering and removing plaque emboli from the body. This investigation studied one FDA-approved DPF, RX Accunet, using both in vitro and computational methods.
- Bioengineering Division
Experimental and Computational Evaluation of Embolic Protection
- Views Icon Views
- Share Icon Share
- Search Site
Siewiorek, GM, & Finol, EA. "Experimental and Computational Evaluation of Embolic Protection." Proceedings of the ASME 2010 Summer Bioengineering Conference. ASME 2010 Summer Bioengineering Conference, Parts A and B. Naples, Florida, USA. June 16–19, 2010. pp. 627-628. ASME. https://doi.org/10.1115/SBC2010-19693
Download citation file: